PAM
ARIA

Panagora Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Panagora Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-66,707
Closed -$830K – 2522
2016
Q4 		$830K Sell
66,707
-27,881
-29% -$336K ﹤0.01% 1263
2016
Q3 		$1.29M Buy
94,588
+64,594
+215% +$649K 0.01% 1087
2016
Q2 		$222K Hold
29,994
– – ﹤0.01% 1633
2016
Q1 		$192K Sell
29,994
-3,245
-10% -$18.2K ﹤0.01% 1668
2015
Q4 		$208K Sell
33,239
-1,183
-3% -$7.76K ﹤0.01% 1581
2015
Q3 		$201K Buy
34,422
+31,778
+1,202% +$245K ﹤0.01% 1600
2015
Q2 		$22K Sell
2,644
-21,710
-89% -$192K ﹤0.01% 2293
2015
Q1 		$201K Buy
+24,354
New +$180K ﹤0.01% 1669
2013
Q4 		– Sell
-2,771
Closed -$51K – 2310
2013
Q3 		$51K Buy
+2,771
New +$53.8K ﹤0.01% 2012

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Panagora Asset Management's ARIA Position: Q1 2017 in Review

Panagora Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 66,707 shares — an estimated $830K sold.

Panagora Asset Management first reported a position in ARIA in Q3 2013 and held it in 9 quarters. The position peaked at $1.29M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Panagora Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 66,707 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $830K.
  • Panagora Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 9 quarters.
  • Panagora Asset Management's Ariad Pharmaceuticals Inc position peaked at $1.29M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.